• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.29% Nasdaq Down0.03%

    Sorrento Therapeutics, Inc. (SRNE)

    -NasdaqCM
    12.94 Down 0.27(2.04%) May 22, 4:00PM EDT
    |After Hours : 13.00 Up 0.05 (0.39%) May 22, 4:02PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 977   798   1,276   775  
    Cost of Revenue509  443  527  510  
    Gross Profit 468   355   749   265  
    Operating Expenses
    Research Development7,840  7,127  5,440  5,309  
    Selling General and Administrative2,219  2,387  1,854  2,361  
    Non Recurring -   -   -   -  
    Others586  587  586  586  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (10,177) (9,746) (7,131) (7,991)
    Income from Continuing Operations
    Total Other Income/Expenses Net -  1  2  5  
    Earnings Before Interest And Taxes(10,177)(9,745)(7,129)(7,986)
    Interest Expense439  462  476  468  
    Income Before Tax(10,616)(10,207)(7,605)(8,454)
    Income Tax Expense(178)(1,702) -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(10,438)(8,505)(7,605)(8,454)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (10,438) (8,505) (7,605) (8,454)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (10,438) (8,505) (7,605) (8,454)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.